Table 4:

Patients with recurrence

Variable	No Recurrence	Recurrence	p value
	n=336 (%)	n=62 (%)
			0.29
Not Prescribed Decolonization	239 (71.1%)	40 (64.5%)
Prescribed Decolonization	97 (28.9%)	22 (35.5%)
Risk Factors
Immunocompromised	11 (3.3%)	3 (4.8%)	0.55
Cardiac Disorder	3 (4.8%)	5 (8.0%)	0.05
Attended Day Care	68 (20.2%)	14 (22.6%)	0.8
Prior Hx of abscess/cellulitis	61 (18.2%)	23 (37.1%)	0.004
Prior Hx of MRSA	24 (7.1%)	10 (16.1%)	0.04
# of family members with Hx of abscess/cellulitis (mean ± SD)	0.23 ±0.55	0.53 ± 0.89	0.002
# of family members with Hx MRSA (mean ± SD)	0.08 ±0.36	0.26 ±0.59	0.0003
Previous hospitalization that year	44 (13.1%)	13 (21.0%)	0.12
Community-acquired MRSA	317 (94.3%)	59 (95.2%)	0.99
Hospital-acquired MRSA	19 (5.7%)	3 (4.8%)
Indwelling catheter or device	1 (0.3%)	0	0.99
Clinical Factors and Outcomes
Duration of symptoms prior to presentation (mean ± SD, days)	4.42 ± 6.14	4.22 ± 3.25	0.51
Size of abscess (mean ± SD, cm)	4.32 ± 2.88	4.49 ± 3.40	0.97
Fever	122 (36.2%)	31 (50.0%)	0.047
Leukocytosis	157 (82.2%)	33 (91.7%)	0.22
Nasal MRSA Screen	23 (6.8%)	4 (6.5%)	0.99
Antibiotics administered			0.27
None	1 (0.3%)	0
PO antibiotics only	12 (3.6%)	4 (6.5%)
IV antibiotics only	176 (52.5%)	38 (61.3%)
Both PO and IV antibiotics	146 (43.6%)	20 (32.3%)
Length of Stay (mean ± SD, days)	70.35 ± 73	62.6 ± 46	0.65